Details up front: a 29G needle · dulaglutide · 2 mg/mL.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
What does each option buy me, and what does it cost me?
At 2 mg/mL a 1 mg dose is 0.5 mL — 50 units on a U-100 barrel — and no needle gauge changes that number. Gauge changes three other things: how long the draw takes, how much stays behind in the hub, and how much rubber you core out of the stopper. On the 29G scale a larger number is a finer needle, so a 29G needle is fine enough that a viscous solution draws slowly and a hurried draw pulls bubbles. If you are drawing 50 units at a time, the dead space matters more than the bore: a fixed-needle barrel loses microlitres, a luer hub loses tens of them, and at 2 mg/mL each microlitre is 2 µg.
Answer first: use the largest bore you tolerate for drawing and the smallest for injecting, because the two operations have opposite requirements.
For injecting, 29G to 31G is the usual range and the difference in perceived discomfort between them is small. Needle length matters more than gauge for comfort at these volumes.
Stopper coring — punching a disc of rubber into the solution — is a large-bore phenomenon. An 18G or 21G needle inserted straight and fast is the classic way to do it; inserting at a slight angle with the bevel up reduces the risk.
The Hagen–Poiseuille relation gives flow proportional to the fourth power of radius, which is the quantitative basis for every gauge recommendation here.
Flow goes as the fourth power of radius. That is why the difference feels so large.
edited 20 Jul 2024 by thermal_mass — corrected a unit error in the worked example
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemStart with the fact that gauge numbers run backwards — a higher number is a thinner needle — which is the source of half the confusion in this tag.
A 30G or 31G needle through a butyl stopper leaves a track that reseals, which is why fine-gauge repeated entry is tolerable and coarse-gauge repeated entry is not.
Very fine needles are more prone to bending and to blocking with any particulate, which is a practical argument for inspecting the solution before drawing.
Gauge numbers run backwards. Higher number, thinner needle.
The short version: 21G to 23G to draw, 29G to 31G to inject, and never the same needle for both.
Flow through a needle scales with the fourth power of the internal radius under the Hagen–Poiseuille relation. Halving the radius reduces flow sixteen-fold at the same pressure, which is why a 31G needle draws so much more slowly than a 21G.
Typical outer diameters: 21G is about 0.82 mm, 23G about 0.64 mm, 25G about 0.51 mm, 29G about 0.34 mm and 31G about 0.26 mm. The gauge number and the diameter move in opposite directions.
Length affects comfort more than gauge does at these volumes.
The honest answer is that injection gauge is a comfort decision and drawing gauge is a stopper-coring decision.
Fixed-needle insulin syringes are supplied in 29G to 31G and cannot be swapped for drawing, which is the trade-off against their much lower dead space.
Coring risk as a function of needle gauge and insertion technique is documented in pharmacy compounding guidance.
Angle the bevel and insert gently to avoid coring the stopper.
edited 20 Jul 2024 by laminar_bench — added a caveat about sampling
Specifically, for a 4 mm pen-style needle the gauge options are narrow and the choice is nearly made for you.
Drawing a viscous or foamy solution through a fine needle takes long enough that people rush the plunger, which causes more foaming. Using a wider drawing needle is the fix.
The caveat is that no gauge choice makes a non-sterile preparation safe, and research-use compounds are not approved for human use.
Big to draw, small to inject, never the same one twice.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.